Playback speed
10 seconds
Dabrafenib/Trametinib for BRAF V600E Mutation-Positive Advanced NSCLC
By
Beacon Medical Interchange
FEATURING
Jack West
By
Beacon Medical Interchange
FEATURING
Jack West
21 views
November 2, 2018
Dr. Jack West reviews data on the FDA-approved combination of dabrafenib/trametinib for patients with BRAF ...
read more ↘ V600E mutation-positive advanced NSCLC, as published by Blanchard & colleagues in Lancet Oncology.
↖ read less
read more ↘ V600E mutation-positive advanced NSCLC, as published by Blanchard & colleagues in Lancet Oncology.
↖ read less
Comments 0
Login to view comments.
Click here to Login
Lung